SNG today vs OBD16 May 2022 14:35
Look at SNG today on positive news from a trial for a covid drug which they are presenting to a major conference today. OBD, have a test to define the best course of action for cancer treatment. It will save health systems millions of pounds and ensure that cancer patients electing for ICU treatment get the best treatment at once. OBD's test is already approved and in use in US hospitals, and the company is expecting buys from big pharma. This is a credible expectation. They have worked with half the big name pharmas you can think of including giants like GSK. They have 3 proposals in and those big pharma will be looking at the data from early adopters in US hospitals which will be presented to a major conference on June 2nd this year. This is as low risk as you will get on Aim. Already FDA approved. The market is huge- 15% of cancer patients elect for ICU over chemo. Won't be long before medical insurance companies expect this test to be used routinely. Director buys already in. A steal at this price. I'm expecting about £2 before the end of the Summer.